Profil
Charles Brenner is the founder of Healthspan Research LLC and Athena Therapeutics LLC.
He holds no specific job titles in either company, but his job function code is FOU, indicating that he is the founder.
Aktive Positionen von Charles Brenner
| Unternehmen | Position | Beginn |
|---|---|---|
Healthspan Research LLC
 Healthspan Research LLC Medical/Nursing ServicesHealth Services Healthspan Research LLC develops medical products. The company was founded by Charles Brenner and Robert N. Fried and is headquartered in Newport Beach, CA. | Gründer | - |
Ehemalige bekannte Positionen von Charles Brenner
| Unternehmen | Position | Ende |
|---|---|---|
Athena Therapeutics LLC
 Athena Therapeutics LLC Pharmaceuticals: MajorHealth Technology Athena Therapeutics LLC has developed innovative methods to identify and study altered states of NAD metabolism and is creating new types of small molecules to target multiple nodes in NAD synthesis pathways. Athena Therapeutics is based in New Haven, CT and was founded by Ranjit S. Bindra and Charles Brenner. The company has recruited a team of researchers with expertise in NAD metabolism, led by Dr. Emmanuel Burgos, and has established a scientific advisory board of world experts, including Professor Vern Schramm and Dr. Leonard Post. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Healthspan Research LLC
Healthspan Research LLC Medical/Nursing ServicesHealth Services Healthspan Research LLC develops medical products. The company was founded by Charles Brenner and Robert N. Fried and is headquartered in Newport Beach, CA. | Health Services |
Athena Therapeutics LLC
Athena Therapeutics LLC Pharmaceuticals: MajorHealth Technology Athena Therapeutics LLC has developed innovative methods to identify and study altered states of NAD metabolism and is creating new types of small molecules to target multiple nodes in NAD synthesis pathways. Athena Therapeutics is based in New Haven, CT and was founded by Ranjit S. Bindra and Charles Brenner. The company has recruited a team of researchers with expertise in NAD metabolism, led by Dr. Emmanuel Burgos, and has established a scientific advisory board of world experts, including Professor Vern Schramm and Dr. Leonard Post. | Health Technology |
